TLR4 inactivation protects from graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Cellular and Molecular Immunology

Volumn 10, Issue 2, 2013, Pages 165-175

  Zhao, Yi ^a   Liu, Qiuyan ^b   Yang, Li ^a   He, Donghua ^a   Wang, Lijuan ^a   Tian, Jun ^b   Li, Yi ^a   Zi, Fuming ^a   Bao, Hanying ^a   Yang, Yang ^a   Zheng, Yuanyuan ^b   Shi, Jimin ^a   Xue, Xingkui ^a   Cai, Zhen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

graft versus host disease; hematopoietic stem cell transplantation; knockout mouse; Toll like receptor 4

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TOLL LIKE RECEPTOR 4;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLOOD LEVEL; BONE MARROW CELL; CELL MATURATION; CELL SPECIFICITY; CELL STIMULATION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; HISTOPATHOLOGY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MORTALITY; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPLEEN CELL; TH1 CELL; TH2 CELL;

ANIMALS; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; SPLEEN; TOLL-LIKE RECEPTOR 4; TRANSPLANTATION, HOMOLOGOUS;

EID: 84874586924     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2012.58     Document Type: Article

References (43)

1. Paczesny S, Hanauer D, Sun Y, Reddy P. New perspectives on the biology of acute GVHD. Bone Marrow Transplant 2010; 45: 1-11.
2. Wysocki CA, Panoskaltsis-Mortari A, Blazar BR, Serody JS. Leukocyte migration and graft-versus-host disease. Blood 2005; 105: 4191-4199.
3. Beilhack A, Schulz S, Baker J, Beilhack GF, Wieland CB, Herman EI et al. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood 2005; 106: 1113-1122.
4. Auffermann-Gretzinger S, Lossos IS, Vayntrub TA, Leong W, Grumet FC, Blume KG et al. Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. Blood 2002; 99: 1442-1448.
5. Gonzalez B, Guerra C, Morris D. Dendritic cells in infectious disease, hypersensitivity, and autoimmunity. Int J Interferon Cytokine Mediator Res 2010; 2: 137-147.
6. Mullighan CG, Bardy PG. New directions in the genomics of allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 127-144.
7. Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine 2008; 42: 145-151.
8. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010; 327: 291-295.
9. Ferrara JL, Reddy P. Pathophysiology of graft-versus-host disease. Semin Hematol 2006; 43: 3-10.
10. Cooke KR, Olkiewicz K, Erickson N, Ferrara JL. The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. J Endotoxin Res 2002; Sect. 441-448.
11. Netea MG, van Deuren M, Kullberg BJ, Cavaillon JM, van der Meer JW. Does the shape of lipid A determine the interaction of LPS with Tolllike receptors? Trends Immunol 2002; 23: 135-139.
12. Beutler B, Poltorak A. The sole gateway to endotoxin response: how LPS was identified as Tlr4, and its role in innate immunity. Drug Metab Dispos 2001; 29: 474-478.
13. Ferwerda B, McCall MB, Verheijen K, Kullberg BJ, van der Ven A, van der Meer JW et al. Functional consequences of Toll-like receptor 4 polymorphisms. Mol Med 2008; 14: 346-352.
14. Raby BA, Klimecki WT, Laprise C, Renaud Y, Faith J, Lemire M et al. Polymorphisms in Toll-like receptor 4 are not associated with asthma or atopy-related phenotypes. Am J Respir Crit Care Med 2002; 166: 1449-1456.
15. Carvalho A, Marques A, Maciel P, Rodrigues F. Study of diseaserelevant polymorphisms in the TLR4 and TLR9 genes: a novel method applied to the analysis of the Portuguese population. Mol Cell Probes 2007; 21: 316-320.
16. Berdeli A, Emingil G, Han Saygan B, Gurkan A, Atilla G, Kose T et al. TLR2 Arg753Gly, TLR4 Asp299Gly and Thr399Ile gene polymorphisms are not associated with chronic periodontitis in a Turkish population. J Clin Periodontol 2007; 34: 551-557.
17. Nebel A, Flachsbart F, Schafer A, Nothnagel M, Nikolaus S, Mokhtari NE et al. Role of the toll-like receptor 4 polymorphism Asp299Gly in longevity and myocardial infarction in German men. Mech Ageing Dev 2007; 128: 409-411.
18. Awomoyi AA, Rallabhandi P, Pollin TI, Lorenz E, Sztein MB, Boukhvalova MS et al. Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J Immunol 2007; 179: 3171-3177.
19. Rezazadeh M, Hajilooi M, Rafiei A, Haidari M, Nikoopour E, Kerammat F et al. TLR4 polymorphism in Iranian patients with brucellosis. J Infect 2006; 53: 206-210.
20. Okayama N, Fujimura K, Suehiro Y, Hamanaka Y, Fujiwara M, Matsubara T et al. Simple genotype analysis of the Asp299Gly polymorphismof the Toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness. J Clin Lab Anal 2002; 16: 56-58.
21. Kim YS, Hwang YJ, Kim SY, Yang SM, Lee KY, Park Ie B. Rarity of TLR4 Asp299Gly and Thr399Ile polymorphisms in the Korean population. Yonsei Med J 2008; 49: 58-62.
22. Elmaagacli AH, Koldehoff M, Hindahl H, Steckel NK, Trenschel R, Peceny R et al. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graftversus-host disease in patients who underwent an allogeneic transplantation. Transplantation 2006; 81: 247-254.
23. Imado T, Iwasaki T, Kitano S, Satake A, Kuroiwa T, Tsunemi S et al. The protective role of host Toll-like receptor-4 in acute graft-versushost disease. Transplantation 2010; 90: 1063-1070.
24. Lorenz E, Schwartz DA, Martin PJ, Gooley T, Lin MT, Chien JW et al. Association of TLR4 mutations and the risk for acute GVHD after HLAmatched-sibling hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 384-387.
25. Calcaterra C, Sfondrini L, Rossini A, Sommariva M, Rumio C, Menard S et al. Critical role of TLR9 in acute graft-versus-host disease. J Immunol 2008; 181: 6132-6139.
26. Yaa MN, Paolo P, Peter S, Eric PG, Jaya S, Papanicolaou GA. Toll-like receptor 4 polymorphisms and risk of Gram-negative bacteremia after allogeneic stem cell transplantation. A prospective pilot study. Biol Blood Marrow Transplant 2009; 15: 1130-1133.
27. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162: 3749-3752.
28. Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte J Jr, Crawford JM et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996; 88: 3230-3239.
29. Asai O, Longo DL, Tian ZG, Hornung RL, Taub DD, Ruscetti FW et al. Suppression of graft-versus-host disease and amplification of graftversus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest 1998; 101: 1835-1842.
30. Bryson JS, Jennings CD, Lowery DM, Carlson SL, Pflugh DL, Caywood BE et al. Rejection of an MHC class II negative tumor following induction of murine syngeneic graft-versus-host disease. Bone Marrow Transplant 1999; 23: 363-372.
31. Xu S, Liu X, Bao Y, Zhu X, Han C, Zhang P et al. ConstitutiveMHCclass I molecules negatively regulate TLR-triggered inflammatory responses via the Fps-SHP-2 pathway. Nat Immunol 2012; 13: 551-559.
32. Liu X, Zhan Z, Li D, Xu L,MaF, Zhang P et al. IntracellularMHCclass II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nat Immunol 2011; 12: 416-424.
33. Han C, Jin J, Xu S, Liu H, Li N, Cao X. Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat Immunol 2010; 11: 734-742.
34. Ma F, Xu S, Liu X, Zhang Q, Xu X, Liu M et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat Immunol 2011; 12: 861-869.
35. Zhang M, Tang H, Guo Z, An H, Zhu X, Song W et al. Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat Immunol 2004; 5: 1124-1133.
36. Hamza T, Barnett JB, Li B. Interleukin 12 a key immunoregulatory cytokine in infection applications. Int J Mol Sci 2010; 11: 789-806.
37. Austrup F, Vestweber D, Borges E, Lhning M, Bruer R, Herz U et al. Pand E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 1997; 385: 81-83.
38. Nikolic B, Lee S, Bronson RT, Grusby MJ, Sykes M. Th1 and Th2 mediate acute graft-versus-host disease, each with distinct endorgan targets. J Clin Invest 2000; 105: 1289-1298.
39. Sun Y, Tawara I, Toubai T, Reddy P. Pathophysiology of acute graftversus-host disease: recent advances. Transl Res 2007; 150: 197-214.
40. Tawara I, Maeda Y, Sun Y, Lowler KP, Liu C, Toubai T et al. Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft versus host disease. Exp Hematol 2008; 36: 988-996.
41. Brok HP, Heidt PJ, van der Meide PH, Zurcher C, Vossen JM. Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Immunol 1993; 151: 6451-6459.
42. Yang YG, Dey BR, Sergio JJ, Pearson DA, Sykes M. Donor-derived interferon gamma is required for inhibition of acute graft-versushost disease by interleukin 12. J Clin Invest 1998; 102: 2126-2135.
43. Murphy WJ, Welniak LA, Taub DD, Wiltrout RH, Taylor PA, Vallera DA et al. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest 1998; 102: 1742-1748.